According to Huiya Wu, JD, an intellectual property law attorney from … of US patent laws to stall adalimumab biosimilar competition there until 2023.
According to Huiya Wu, JD, an intellectual property law attorney from … of US patent laws to stall adalimumab biosimilar competition there until 2023.